Related Experiment Video
Updated: Dec 31, 2025

Author Spotlight: Assessing the Potential of Circulating Tumor Cells in Leptomeningeal Disease Research
Published on: March 29, 2024
Autocrine/paracrine actions of growth hormone in human melanoma cell lines
Ashiya Buckels1, Yue Zhang1, Jing Jiang1
1Department of Medicine Division of Endocrinology, Diabetes, and Metabolism, University of Alabama at Birmingham, Birmingham, AL, USA.
Abstract:
Melanoma is the most aggressive skin cancer. Its aggressiveness is most commonly attributed to ERK pathway mutations leading to constitutive signaling. Though initial tumor regression results from targeting this pathway, resistance often emerges. Interestingly, interrogation of the NCI-60 database indicates high growth hormone receptor (GHR) expression in melanoma cell lines. To further characterize melanoma, we tested responsiveness to human growth hormone (GH). GH treatment resulted in GHR signaling and increased invasion and migration, which was inhibited by a GHR monoclonal antibody (mAb) antagonist in WM35, SK-MEL 5, SK-MEL 28 and SK-MEL 119 cell lines. We also detected GH in the conditioned medium (CM) of human melanoma cell lines. GHR, JAK2 and STAT5 were basally phosphorylated in these cell lines, consistent with autocrine/paracrine GH production. Together, our results suggest that melanomas are enriched in GHR and produce GH that acts in an autocrine/paracrine manner. We suggest that GHR may constitute a therapeutic target in melanoma.
Insights
Melanoma cells highly express the growth hormone receptor (GHR). Targeting GHR with an antibody blocked melanoma cell invasion and migration, suggesting GHR as a potential therapeutic target for this aggressive skin cancer.
Area of Science:
- Oncology
- Endocrinology
- Molecular Biology
Background:
- Melanoma is an aggressive skin cancer often driven by ERK pathway mutations.
- Resistance to targeted therapies necessitates exploring alternative treatment strategies.
- High growth hormone receptor (GHR) expression in melanoma cell lines was observed in the NCI-60 database.
Purpose of the Study:
- To investigate the role of growth hormone receptor (GHR) signaling in melanoma.
- To determine the effect of human growth hormone (GH) on melanoma cell behavior.
- To evaluate the therapeutic potential of targeting GHR in melanoma.
Main Methods:
- Analysis of NCI-60 database for GHR expression in melanoma cell lines.
- Treatment of melanoma cell lines (WM35, SK-MEL 5, SK-MEL 28, SK-MEL 119) with human growth hormone (GH).
- Assessment of GHR signaling, invasion, and migration following GH treatment.
- Inhibition studies using a GHR monoclonal antibody (mAb) antagonist.
- Detection of GH in conditioned medium (CM) from melanoma cell lines.
- Analysis of basal phosphorylation of GHR, JAK2, and STAT5.
Main Results:
- GH treatment activated GHR signaling in melanoma cell lines.
- GH significantly increased melanoma cell invasion and migration.
- A GHR mAb antagonist inhibited GH-induced invasion and migration.
- Human melanoma cell lines produce GH, indicating autocrine/paracrine signaling.
- Basal phosphorylation of GHR, JAK2, and STAT5 suggests constitutive signaling.
Conclusions:
- Melanoma cells exhibit high expression of GHR and produce GH.
- GH acts in an autocrine/paracrine manner to promote melanoma cell invasion and migration.
- GHR represents a potential therapeutic target for melanoma treatment.
Related Concept Videos
Mitogens and the Cell Cycle
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Abnormal Proliferation
TGF - β Signaling Pathway
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...

